Antiphospholipid Syndrome Related Thrombosis: Understanding the disease pathogenic mechanisms is the key to better diagnosis and treatment

点击翻译按钮获取中文摘要

Patients with the Antiphospholipid Syndrome develop thrombosis at a young age. It requires long-term treatment with blood thinning medications, which have risks of severe bleeding. Methods are needed to decide which patients require long term treatment, avoiding unnecessary treatment in low risk patients. Such methods do not currently exist. In this study we explore how useful two novel assays developed by us are in identifying which of these patients are at high risk of thrombosis.